酮症倾向 2 型糖尿病的危险因素综述 

李嘉欣 毕长龙 

中山大学附属第八医院内分泌科，广东深圳，518033； 

摘要：酮症倾向 2 型糖尿病以酮症或酮症酸中毒起病，发病类似 1 型糖尿病，而预后类似 2 型糖尿病，临床表现 较为独特。临床上对酮症或酮症酸中毒起病的糖尿病患者进行早期分类并不容易。本文对酮症倾向 2 型糖尿病的 临床特征进行总结，并且归纳与酮症倾向 2 型糖尿病有关的危险因素和预测模型，为酮症倾向 2 型糖尿病的早期 识别和科学管理提供思路。 

关键词：酮症倾向 2 型糖尿病；危险因素；临床特征；诊断；预测模型 

参考文献

[1]WINTER W E, MACLAREN N K, RILEY W J, et al. Maturity-onset diabetes of youth in black Americans [J]. The New England journal of medicine, 1987, 316(6): 285-91.

[2]BANERJI M A, CHAIKEN R L, HUEY H, et al. GAD antibody negative NIDDM in adult black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes [J]. Diabetes, 1994, 43(6): 741-5.

[3]JI B, SURESH S, BALLY K, et al. Ketosis-Prone Type 2 Diabetes (Flatbush Diabetes) in Remission: A Report of Two Cases [J]. Cureus, 2022, 14(8): e28514.

[4]MCFARLANE S I, CHAIKEN R L, HIRSCH S, et al. Near-normoglycaemic remission in African-Americans with Type 2 diabetes mellitus is associated with recovery of beta cell function [J]. Diabetic medicine : a journal of the British Diabetic Association, 2001, 18(1): 10-6.

[5]MAUVAIS-JARVIS F, SOBNGWI E, PORCHER R, et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance [J]. Diabetes, 2004, 53(3): 645-53.

[6]MALDONADO M, HAMPE C S, GAUR L K, et al. Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and beta-cell functional classification, prospective analysis, and clinical outcomes [J]. The Journal of clinical endocrinology and metabolism, 2003, 88(11): 5090-8.

[7]IWASAKI Y, HAMAMOTO Y, KAWASAKI Y, et al. Japanese cases of acute onset diabetic ketosis without acidosis in the absence of glutamic acid decarboxylase autoantibody [J]. Endocrine, 2010, 37(2): 286-8.

[8]ZHANG M, LI Y, CUI W, et al. THE CLINICAL AND METABOLIC CHARACTERISTICS OF YOUNG-ONSET KETOSIS-PRONE TYPE 2 DIABETES IN CHINA [J]. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2015, 21(12): 1364-71.

[9]YAN S H, SHEU W H, SONG Y M, et al. The occurrence of diabetic ketoacidosis in adults [J]. Internal medicine (Tokyo, Japan), 2000, 39(1): 10-4.

[10]GUPTA R D, RAMACHANDRAN R, GANGADHARA P, et al. Clinical characteristics, beta-cell dysfunction and treatment outcomes in patients with A-β+ Ketosis-Prone Diabetes (KPD): The first identified cohort amongst Asian Indians [J]. Journal of diabetes and its complications, 2017, 31(9): 1401-7.

[11]SEOK H, JUNG C H, KIM S W, et al. Clinical characteristics and insulin independence of Koreans with new-onset type 2 diabetes presenting with diabetic ketoacidosis [J]. Diabetes/metabolism research and reviews, 2013, 29(6): 507-13.

[12]BALASUBRAMANYAM A, ZERN J W, HYMAN D J, et al. New profiles of diabetic ketoacidosis: type 1 vs type 2 diabetes and the effect of ethnicity [J]. Archives of internal medicine, 1999, 159(19): 2317-22.

[13]YAMADA K, NONAKA K. Diabetic ketoacidosis in young obese Japanese men [J]. Diabetes care, 1996, 19(6): 671.

[14]WADDANKERI S S, SWARAJ WADDANKERI M, GURUSHANTAPPA MANGSHETTY B. Clinical and Biochemical Characteristics and Treatment Outcomes of Ketosis-Prone Diabetes: The Remission Prone Diabetes [J]. International journal of endocrinology and metabolism, 2021, 19(2): e106799.

[15]LEBOVITZ H E, BANERJI M A. Ketosis-Prone Diabetes (Flatbush Diabetes): an Emerging Worldwide Clinically Important Entity [J]. Current diabetes reports, 2018, 18(11): 120.

[16]SATOMURA A, OIKAWA Y, HAISA A, et al. Bodyweight threshold for sudden onset of ketosis might exist in ketosis-prone type 2 diabetes patients [J]. Journal of diabetes investigation, 2020, 11(2): 499-501.

[17]MIN R, LIAO Y, PENG B. Development and validation of a novel nomogram for prediction of ketosis-prone type 2 diabetes [J]. Frontiers in endocrinology, 2023, 14: 1235048.

[18]JIANG Y, ZHU J, LAI X. Development and Validation of a Risk Prediction Model for Ketosis-Prone Type 2 Diabetes Mellitus Among Patients Newly Diagnosed with Type 2 Diabetes Mellitus in China [J]. Diabetes, metabolic syndrome and obesity : targets and therapy, 2023, 16: 2491-502.

[19]ZHENG J, SHEN S, XU H, et al. Development and validation of a multivariable risk prediction model for identifying ketosis-prone type 2 diabetes [J]. Journal of diabetes, 2023, 15(9): 753-64.

[20]MIN R, XU Y, PENG B. The clinical value of glycosylated hemoglobin level in newly diagnosed ketosis-prone type 2 diabetes [J]. Frontiers in endocrinology, 2023, 14: 1244008.

[21]ZHU B, BU L, ZHANG M, et al. HbA(1c) as a Screening tool for Ketosis in Patients with Type 2 Diabetes Mellitus [J]. Scientific reports, 2016, 6: 39687.

[22]HE X, LUO Y, HAO J, et al. Association Between Serum Vitamin D Levels and Ketosis Episodes in Hospitalized Patients with Newly Diagnosed Ketosis-Prone Type 2 Diabetes [J]. Diabetes, metabolic syndrome and obesity : targets and therapy, 2022, 15: 3821-9.

[23]YE S, RAN H, ZHANG H, et al. Elevated Serum Triglycerides are Associated with Ketosis-Prone Type 2 Diabetes in Young Individuals [J]. Diabetes, metabolic syndrome and obesity : targets and therapy, 2021, 14: 497-504.

[24]XIE X J, HU Y, CHENG C, et al. Should diabetic ketosis without acidosis be included in ketosis-prone type 2 diabetes mellitus? [J]. Diabetes/metabolism research and reviews, 2014, 30(1): 54-9.

[25]QI M, SHAO X, LI D, et al. Establishment and validation of a clinical model for predicting diabetic ketosis in patients with type 2 diabetes mellitus [J]. Frontiers in endocrinology, 2022, 13: 967929.

[26]ZHU B, LIN Z, CHEN X, et al. Circulating osteocalcin: A potential predictor of ketosis in type 2 diabetes [J]. Diabetes/metabolism research and reviews, 2020, 36(4): e3265.

[27]FERRON M, HINOI E, KARSENTY G, et al. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice [J]. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(13): 5266-70.

[28]LIU D M, GUO X Z, TONG H J, et al. Association between osteocalcin and glucose metabolism: a meta-analysis [J]. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2015, 26(12): 2823-33.

[29]KARTHIKEYAN J, RAJARAGUPATHY S. Diagnostic Usefulness of Serum Albumin as a Predictor of Diabetic Ketoacidosis [J]. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 2018, 22(10): 733-6.

[30]CHENG P C, HSU S R, CHENG Y C. Association between Serum Albumin Concentration and Ketosis Risk in Hospitalized Individuals with Type 2 Diabetes Mellitus [J]. Journal of diabetes research, 2016, 2016: 1269706.

[31]LI H, SU B, LI G Z. Development and validation of a nomogram for screening patients with type 2 diabetic ketoacidosis [J]. BMC endocrine disorders, 2024, 24(1): 148.

[32]LOUET J F, SMITH S B, GAUTIER J F, et al. Gender and neurogenin3 influence the pathogenesis of ketosis-prone diabetes [J]. Diabetes, obesity & metabolism, 2008, 10(10): 912-20.

[33]JAHOOR F, HSU J W, MEHTA P B, et al. Metabolomics Profiling of Patients With A-β+ Ketosis-Prone Diabetes During Diabetic Ketoacidosis [J]. Diabetes, 2021, 70(8): 1898-909.

利益冲突声明：所有作者声明不存在利益冲突.

作者贡献声明：李嘉欣：提出论文设想，设计论文框架，进行文献调研与整理，撰写与修订论文；毕长龙：提供论文写作指导，补充文献调研，修订并审核论文.